上尿路尿路上皮癌（Upper tract urothelial carcinoma，UTUC）是一种泌尿系相对罕见的疾病，其双侧发病则更为罕见。病因学上，UTUC 和膀胱癌有一些共同的致病因素，但两种疾病在临床特征和外科治疗上则不尽相同。随着泌尿外科腹腔镜手术的普及，腹腔镜下根治性肾 - 输尿管切除术和膀胱袖口状切除术（Laparoscopic nephroureterectomy with bladder cuff excision，LNUBCE）已经成为泌尿外科治疗 UTUC 的主流方法。机器人外科手术系统因其直观清晰的手术视觉效果和较高的灵敏度，弥补了腹腔镜手术存在的缺陷，使机器人根治性肾 - 输尿管切除术和膀胱袖口状切除术（Robotic nephroureterectomy with bladder cuff excision，RNUBCE）逐渐被大家所接受。本文对近年机器人手术系统在双侧上尿路尿路上皮癌治疗中的应用和研究进展进行综述。

Upper tract urothelial carcinoma (UTUC) is relatively rare in urinary system diseases, while the bilateral incidence is even rarer. Etiologically, UTUC and bladder cancer share some risk factors, but the two diseases are not same on clinical features and surgical treatment. With the popularity of laparoscopy, laparoscopic nephroureterectomy with bladder cuff excision (LNUBCE) has become the main surgical treatment way to UTUC. With intuitive and clear visual effect and high sensitivity, robotic surgery system overcomes many defects of laparoscopic surgery, so that robotic nephroureterectomy with bladder cuff excision (RNUBCE) is gradually accepted by the public. This study reviews the application and research progress of robotic surgical system in the treatment of bilateral UTUC in recent years.

收稿日期：2021-08-07  录用日期：2021-11-20 

Received Date: 2021-08-07  Accepted Date: 2021-11-20 

基金项目：河南省自然科学基金资助项目（182300410341）

Foundation Item: Natural Science Foundation of Henan Province(182300410341)

通讯作者：贾占奎，Email：jiazhankui@126.com

Corresponding Author: JIA Zhankui, Email: jiazhankui@126.com 

引用格式：冯源康，王军，李翔，等 . 机器人辅助技术在双侧上尿路尿路上皮癌治疗中的应用和研究进展 [J]. 机器人外科学杂志（中英文），2022，3（2）：120-124. 

Citation: FENG Y K, WANG J, LI X, et al. Application and research progress of robotic technology in treating bilateral upper tract urothelial carcinoma [J]. Chinese Journal of Robotic Surgery, 2022, 3(2):120-124.

[1] Kenigsberg A P, Smith W, Meng X, et al. Robotic nephroureterectomy vs laparoscopic nephroureterectomy: increased utilization, rates of lymphadenectomy, decreased morbidity robotically[J]. J Endourol, 2021, 35(3): 312-318. 

[2] 彭程 , 黄庆波 , 朱捷 , 等 . 基于三维影像重建的肾窦内肿瘤手术难度评分系统 [J]. 机器人外科学杂志 ( 中英文 ), 2020, 1(5): 345-354. 

[3] Peyronnet B, Seisen T, Dominguez-Escrig J L, et al. Oncological outcomes of laparoscopic nephroureterectomy versus open radical nephroureterectomy for upper tract urothelial carcinoma: an european association of urology guidelines systematic review[J]. Eur Urol Focus, 2019, 5(2): 205-223. 

[4] Fairey A S, Kassouf W, Estey E, et al. Comparison of oncological outcomes for open and laparoscopic radical nephroureterectomy: results from the canadian upper tract collaboration[J]. BJU Int, 2013, 112(6): 791-797. 

[5] FANG D, XIONG G, L I X, et al. Incidence, characteristics, treatment strategies, and oncologic outcomes of synchronous bilateral upper tract urothelial carcinoma in the Chinese population[J]. Urol Oncol, 2015, 33(2): 66 e1-11.

[6] Hubosky S G, Boman B M, Charles S, et al. Ureteroscopic management of upper tract urothelial carcinoma (UTUC) in patients with Lynch Syndrome (hereditary nonpolyposis colorectal cancer syndrome)[J]. BJU Int, 2013, 112(6): 813-819. 

[7] 康永明 , 方冬 , 李学松 , 等 . 双侧上尿路尿路上皮癌 30 例临床诊疗分析 [J]. 首都医科大学学报 , 2014, 35(3): 290-294.

[8] Vasen H F, Moslein G, Alonso A, et al. Guidelines for the clinical management of Lynch syndrome (hereditary nonpolyposis cancer)[J]. J Med Genet, 2007, 44(6): 353-362. 

[9] Audenet F, Colin P, Yates D R, et al. A proportion of hereditary upper urinary tract urothelial carcinomas are misclassified as sporadic according to a multiinstitutional database analysis: proposal of patientspecific risk identification tool[J]. BJU Int, 2012, 110(11 Pt B): E583-E589. 

[10] Crockett D G, Wagner D G, Holmang S, et al. Upper urinary tract carcinoma in Lynch syndrome cases[J]. J Urol, 2011, 185(5): 1627-1630. 

[11] Huang W C, Levey A S, Serio A M, et al. Chronic kidney disease after nephrectomy in patients with renal cortical tumours: a retrospective cohort study[J]. Lancet Oncol, 2006, 7(9): 735-740.

[12] Matsui Y, Utsunomiya N, Ichioka K, et al. Risk factors for subsequent development of bladder cancer after primary transitional cell carcinoma of the upper urinary tract[J]. Urology, 2005, 65(2): 279-283. 

[13] O’brien T, Ray E, Singh R, et al. Prevention of bladder tumours after nephroureterectomy for primary upper urinary tract urothelial carcinoma: a prospective, multicentre, randomised clinical trial of a single postoperative intravesical dose of mitomycin C (the ODMIT-C Trial)[J]. Eur Urol, 2011, 60(4): 703-710. 

[14] Holmang S, Johansson S L. Synchronous bilateral ureteral and renal pelvic carcinomas: incidence, etiology, treatment and outcome[J]. Cancer, 2004, 101(4): 741-747. 

[15] Roscigno M, Shariat S F, Margulis V, et al. Impact of lymph node dissection on cancer specific survival in patients with upper tract urothelial carcinoma treated with radical nephroureterectomy[J]. J Urol, 2009, 181(6): 2482-2489.

[16] Marits P, Karlsson M, Sherif A, et al. Detection of immune responses against urinary bladder cancer in sentinel lymph nodes[J]. Eur Urol, 2006, 49(1): 59-70. 

[17] Krantz D, Hartana C A, Winerdal M E, et al. Neoadjuvant chemotherapy reinforces antitumour t cell response in urothelial urinary bladder cancer[J]. Eur Urol, 2018, 74(6): 688-692. 

[18] Kondo T, Nakazawa H, Ito F, et al. Impact of the extent of regional lymphadenectomy on the survival of patients with urothelial carcinoma of the upper urinary tract[J]. J Urol, 2007, 178(4 Pt 1): 1212-1217; discussion 1217.

[19] Roupret M, Babjuk M, Comperat E, et al. European association of urology guidelines on upper urinary tract urothelial carcinoma: 2017 update[J]. Eur Urol, 2018, 73(1): 111-122. 

[20] Xylinas E, Rink M, Cha E K, et al. Impact of distal ureter management on oncologic outcomes following radical nephroureterectomy for upper tract urothelial carcinoma[J]. Eur Urol, 2014, 65(1): 210-217.

[21] Favaretto R L, Shariat S F, Chade D C, et al. Comparison between laparoscopic and open radical nephroureterectomy in a contemporary group of patients: are recurrence and disease-specific survival associated with surgical technique?[J]. Eur Urol, 2010, 58(5): 645-651. 

[22] Ghezzi T L, Corleta O C. 30 Years of robotic surgery[J]. World J Surg, 2016, 40(10): 2550-2557.

[23] Muaddi H, Hafid M E, Choi W J, et al. Clinical outcomes of robotic surgery compared to conventional surgical approaches (laparoscopic or open): a systematic overview of reviews[J]. Ann Surg, 2021, 273(3): 467-473.

[24] Spaggiari M, Di Cocco P, Tulla K, et al. Simultaneous robotic kidney transplantation and bariatric surgery for morbidly obese patients with end-stage renal failure[J]. Am J Transplant, 2021, 21(4): 1525-1534. 

[25] 贾占奎 , 王涛 , 邢会武 , 等 . 单一体位、原通道经腹入路 RANU 在治疗上尿路尿路上皮癌中的应用 [J]. 中华泌尿外科杂志 , 2020, 41(7): 503-506.

[26] 王卫平 , 吴震杰 , 徐红 , 等 . 机器人全腹膜外肾输尿管全长及膀胱袖状切除术的初步临床应用 [J]. 中华泌尿外科杂志 , 2018, 39(3): 161-165. 

[27] 杨诚 , 梁朝朝 . 机器人辅助腹腔镜肾输尿管全长切除术的应用进展 [J]. 中华泌尿外科杂志 , 2021, 42(6): 477-480. 

[28] 后森林 , 侯俊清 , 张建华 , 等 . 上尿路尿路上皮癌治疗方式的选择 [J]. 临床泌尿外科杂志 , 2021, 36(6): 496-501.